1. MINSALUD M de S y PS. Encuesta Nacional de Salud Mental 2015. Tomo I. 2015. 384 p. 2. von dem Knesebeck O, Mnich E, Daubmann A, Wegscheider K, Angermeyer MC, Lambert M, et al. Socioeconomic status and beliefs about depression, schizophrenia and eating disorders. Social Psychiatry and Psychiatric Epidemiology. 2013 May;48(5):775–82. 3. Rojas-Villarraga A, Amaya-Amaya J, Rodriguez-Rodriguez A, Mantilla RD, Anaya J-M. Introducing polyautoimmunity: secondary autoimmune diseases no longer exist. Autoimmune diseases [Internet]. 2012;2012(1):254319. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22454759 4. Lerner A, Jeremias P, Matthias T. The World Incidence and Prevalence of Autoimmune Diseases is Increasing. International Journal of Celiac Disease. 2015 Nov;3(4):151–5. 5. Westhoff G, Dörner T, Zink A. Fatigue and depression predict physician visits and work disability in women with primary Sjögren’s syndrome: results from a cohort study. Rheumatology [Internet]. 2012 Feb;51(2):262–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21705778 6. Rogers HL, Brotherton HT, Olivera Plaza SL, Segura Durán MA, Peña Altamar ML. Depressive and anxiety symptoms and social support are independently associated with disease-specific quality of life in Colombian patients with rheumatoid arthritis. Revista brasileira de reumatologia [Internet]. 2015;55(5):406–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25816759 7. Thombs BD, Taillefer SS, Hudson M, Baron M. Depression in patients with systemic sclerosis: a systematic review of the evidence. Arthritis and rheumatism [Internet]. 2007 Aug 15;57(6):1089–97. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17665491 8. Baubet T, Ranque B, Taïeb O, Bérezné A, Bricou O, Mehallel S, et al. Mood and anxiety disorders in systemic sclerosis patients. Presse medicale [Internet]. 2011 Feb;40(2):e111-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21055901 9. Kheirandish M, Faezi ST, Paragomi P, Akhlaghi M, Gharibdoost F, Shahali A, et al. Prevalence and severity of depression and anxiety in patients with systemic lupus erythematosus: An epidemiologic study in Iranian patients. Modern rheumatology [Internet]. 2015 May;25(3):405–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25295916 11. Smith BW, Dalen J, Wiggins K, Tooley E, Christopher P, Bernard J. The brief resilience scale: assessing the ability to bounce back. International journal of behavioral medicine [Internet]. 2008;15(3):194–200. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18696313 12. Najjar S, Pearlman DM, Alper K, Najjar A, Devinsky O. Neuroinflammation and psychiatric illness. Journal of neuroinflammation [Internet]. 2013 Apr 1;10(1):43. Available from: http://jneuroinflammation.biomedcentral.com/articles/10.1186/1742-2094-10-43 13. Cal SF, Santiago MB. Resilience in systemic lupus erythematosus. Psychology, health & medicine [Internet]. 2013;18(5):558–63. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23350645 14. Liu L, Xu X, Xu N, Wang L. Disease activity, resilience and health-related quality of life in Chinese patients with rheumatoid arthritis: a multi-center, cross-sectional study. Health and quality of life outcomes [Internet]. 2017 Jul 24;15(1):149. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28738816 15. Margarita J, Vinaccia S. Resiliencia: una perspectiva desde la enfermedad crónica en población adulta. Pensamiento Psicológico. 2011;9(17):69–82. 16. Stewart DE, Yuen T. A systematic review of resilience in the physically ill. Psychosomatics [Internet]. 2011;52(3):199–209. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21565591 17. Tosevski DLDL, Milovancevic MPMP. Stressful life events and physical health. Current Opinion in Psychiatry [Internet]. 2006 Mar;19(2):184–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16612201 18. Quiceno JM, Vinaccia S. Resiliencia, percepción de la enfermedad, creencia y afrontamiento espiritual religioso y calidad de vida relacionada con la salud en pacientes con diagnóstico de artritis reumatoide. Psicol desde el caribe. 2013;30(3):590–619. 19. Smith BW, Zautra AJ. Vulnerability and resilience in women with arthritis: test of a two-factor model. Journal of consulting and clinical psychology [Internet]. 2008 Oct;76(5):799–810. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18837597 20. McEwen BS. Stress, adaptation, and disease. Allostasis and allostatic load. Annals of the New York Academy of Sciences [Internet]. 1998 May 1;840(1):33–44. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9629234 21. Somers TJ, Kurakula PC, Criscione-Schreiber L, Keefe FJ, Clowse MEB. Self-efficacy and pain catastrophizing in systemic lupus erythematosus: relationship to pain, stiffness, fatigue, and psychological distress. Arthritis care & research [Internet]. 2012 Sep;64(9):1334–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22505314 22. Graninger M. [Behavioral training as additional therapy approach for rheumatoid arthritis]. Zeitschrift fur Rheumatologie [Internet]. 2015 Sep;74(7):579–83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26334968 23. Pfau ML, Russo SJ. Peripheral and central mechanisms of stress resilience. Neurobiology of Stress [Internet]. 2015 Jan;1(1):66–79. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2352289514000058 24. Perricone C, Shoenfeld N, Agmon-Levin N, de Carolis C, Perricone R, Shoenfeld Y. Smell and autoimmunity: a comprehensive review. Clinical reviews in allergy & immunology [Internet]. 2013 Aug;45(1):87–96. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23233263 25. Quintero OL, Amador-Patarroyo MJ, Montoya-Ortiz G, Rojas-Villarraga A, Anaya J-M. Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. Journal of autoimmunity [Internet]. 2012 May;38(2–3):J109-19. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22079680 26. Anaya J-M. The diagnosis and clinical significance of polyautoimmunity. Autoimmunity reviews [Internet]. 2014;13(4–5):423–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24424171 27. Anaya J-M, Duarte-Rey C, Sarmiento-Monroy JC, Bardey D, Castiblanco J, Rojas-Villarraga A. Personalized medicine. Closing the gap between knowledge and clinical practice. Autoimmunity reviews [Internet]. 2016 Aug;15(8):833–42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27302209 28. Anaya J-M, Restrepo-Jimenez P, Ramirez-Santana C. The autoimmune ecology: an update. Current opinion in rheumatology. 2018 Feb; In press. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29438164 29. Anaya J-M, Ramirez-Santana C, Alzate MA, Molano-Gonzalez N, Rojas-Villarraga A. The Autoimmune Ecology. Frontiers in immunology [Internet]. 2016;7:139. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27199979 30. Shoenfeld Y, Isenberg DA. The mosaic of autoimmunity. Immunology today [Internet]. 1989 Apr;10(4):123–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2665774 31. Anaya J-M. The autoimmune tautology. Arthritis research & therapy [Internet]. 2010;12(6):147. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21092150 32. Pacheco Y, Barahona-Correa J, Monsalve DM, Acosta-Ampudia Y, Rojas M, Rodríguez Y, et al. Cytokine and autoantibody clusters interaction in systemic lupus erythematosus. Journal of translational medicine [Internet]. 2017 Nov 25;15(1):239. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29178890 33. Kared H, Camous X, Larbi A. T cells and their cytokines in persistent stimulation of the immune system. Current opinion in immunology [Internet]. 2014 Aug;29:79–85. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24880502 34. Rovin BH, Lu L, Zhang X. A novel interleukin-8 polymorphism is associated with severe systemic lupus erythematosus nephritis. Kidney international [Internet]. 2002 Jul;62(1):261–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12081586 35. Yung S, Ng CYC, Au KY, Cheung KF, Zhang Q, Zhang C, et al. Binding of anti-dsDNA antibodies to proximal tubular epithelial cells contributes to renal tubulointerstitial inflammation. Clinical science [Internet]. 2017 Jan 1;131(1):49–67. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27780843 36. Yoshio T, Okamoto H, Kurasawa K, Dei Y, Hirohata S, Minota S. IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus. Lupus [Internet]. 2016 Aug;25(9):997–1003. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26846690 37. Eilertsen GØ, Nikolaisen C, Becker-Merok A, Nossent JC. Interleukin-6 promotes arthritis and joint deformation in patients with systemic lupus erythematosus. Lupus [Internet]. 2011 May;20(6):607–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21422077 38. Voronov E, Dayan M, Zinger H, Gayvoronsky L, Lin J-P, Iwakura Y, et al. IL-1 beta-deficient mice are resistant to induction of experimental SLE. European cytokine network [Internet]. 2006 Jun;17(2):109–16. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16840029 39. Boswell JM, Yui MA, Endres S, Burt DW, Kelley VE. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus. Journal of immunology [Internet]. 1988 Jul 1;141(1):118–24. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3259964 40. Qiu F, Song L, Yang N, Li X. Glucocorticoid downregulates expression of IL-12 family cytokines in systemic lupus erythematosus patients. Lupus [Internet]. 2013 Sep;22(10):1011–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23884985 41. Fuschiotti P, Larregina AT, Ho J, Feghali-Bostwick C, Medsger TA. Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis. Arthritis and rheumatism [Internet]. 2013 Jan;65(1):236–46. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23001877 42. Barnes TC, Anderson ME, Moots RJ. The many faces of interleukin-6: the role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis. International journal of rheumatology [Internet]. 2011;2011:721608. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21941555 43. Rolla G, Fusaro E, Nicola S, Bucca C, Peroni C, Parisi S, et al. Th-17 cytokines and interstitial lung involvement in systemic sclerosis. Journal of breath research [Internet]. 2016 Nov 21;10(4):046013. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27869103 44. Meloni F, Solari N, Cavagna L, Morosini M, Montecucco CM, Fietta AM. Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis. Clinical and experimental rheumatology. 2009;27(5):765–72. 45. Dumoitier N, Chaigne B, Regent A, Lofek S, Mhibik M, Dorfmuller P, et al. Scleroderma Peripheral B Lymphocytes Secrete Interleukin-6 and Transforming Growth Factor beta and Activate Fibroblasts. Arthritis & rheumatology. 2017 May;69(5):1078–89. 46. Zhang L-W, Zhou P-R, Wei P, Cong X, Wu L-L, Hua H. Expression of interleukin-17 in primary Sjögren’s syndrome and the correlation with disease severity: A systematic review and meta-analysis. Scandinavian journal of immunology [Internet]. 2018 Apr;87(4):e12649. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29476557 47. Kirschner M. Systems Medicine: Sketching the Landscape. Methods in molecular biology. 2016;1386:3–15. 48. Calixto O-J, Anaya J-M. Socioeconomic status. The relationship with health and autoimmune diseases. Autoimmunity reviews [Internet]. 2014 Jun;13(6):641–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24418307 49. Jacobi CE, Mol GD, Boshuizen HC, Rupp I, Dinant HJ, Van Den Bos GAM. Impact of socioeconomic status on the course of rheumatoid arthritis and on related use of health care services. Arthritis and rheumatism [Internet]. 2003 Aug 15;49(4):567–73. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12910565 50. Margaretten M, Julian L, Katz P, Yelin E. Depression in patients with rheumatoid arthritis: description, causes and mechanisms. International journal of clinical rheumatology [Internet]. 2011;6(6):617–23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22211138 51. Cadena J, Vinaccia S, Pérez A, Rico MI, Hinojosa R, Anaya J-M. The impact of disease activity on the quality of life, mental health status, and family dysfunction in colombian patients with rheumatoid arthritis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases [Internet]. 2003 Jun;9(3):142–50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17041449 52. Walsh SJ, Gilchrist A. Geographical clustering of mortality from systemic lupus erythematosus in the United States: contributions of poverty, Hispanic ethnicity and solar radiation. Lupus [Internet]. 2006;15(10):662–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17120593 53. Alarcón GS, Bastian HM, Beasley TM, Roseman JM, Tan FK, Fessler BJ, et al. Systemic lupus erythematosus in a multi-ethnic cohort (LUMINA) XXXII: [corrected] contributions of admixture and socioeconomic status to renal involvement. Lupus [Internet]. 2006;15(1):26–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16482742 54. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. The Lancet [Internet]. 2016 Oct;388(10055):2023–38. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673616301738 55. Singh JA, Saag KG, Bridges SL, Akl EA, Bannuru RR, Sullivan MC, et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis & rheumatology [Internet]. 2016 Jan;68(1):1–26. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26545940 56. Sweeney S e., Harris ED, Firestein G s. Clinical Features of Rheumatoid Arthritis. In: Kelly’s Textbook of Rheumatology. 9th ed. Philadelphia; 2013. p. 1109-1136e4. 57. Davis JM, Matteson EL. My Treatment Approach to Rheumatoid Arthritis. Mayo Clinic Proceedings [Internet]. 2012 Jul;87(7):659–73. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0025619612004727 58. Kasturi S, Goldstein BL, Malspeis S, Karlson EW, Costenbader KH. Comparison of the 1987 American College of Rheumatology and the 2010 American College of Rheumatology/European League against Rheumatism Criteria for Classification of Rheumatoid Arthritis in the Nurses’ Health Study Cohorts. Rheumatology international. 2014 Mar;34(3):407–11. 59. Sheehy C, Evans V, Hasthorpe H, Mukhtyar C. Revising DAS28 scores for remission in rheumatoid arthritis. Clinical rheumatology [Internet]. 2014 Feb;33(2):269–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24384827 60. Pincus T, Swearingen CJ, Bergman M, Yazici Y. RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories. The Journal of rheumatology [Internet]. 2008 Nov;35(11):2136–47. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18793006 61. Shah A, St. Clair EW. Rheumatoid Arthritis. In: Kasper D, Fauci A, Hauser S, Longo D, Jameson JL, Loscalzo J, editors. Harrison’s Principles of Internal Medicine, 19e. New York, NY: McGraw-Hill Education; 2015. 62. Marrie RA, Hitchon CA, Walld R, Patten SB, Bolton JM, Sareen J, et al. Increased Burden of Psychiatric Disorders in Rheumatoid Arthritis. Arthritis care & research [Internet]. 2018 Jul;70(7):970–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29438604 63. Lisnevskaia L, Murphy G, Isenberg D. Systemic lupus erythematosus. The Lancet [Internet]. 2014 Nov;384(9957):1878–88. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673614601288 64. Pons-Estel GJ, Ugarte-Gil MF, Alarcón GS. Epidemiology of systemic lupus erythematosus. Expert Review of Clinical Immunology. 2017;13(8):799–814. 65. Fortuna G, Brennan MT. Systemic Lupus Erythematosus: Epidemiology, Pathophysiology, Manifestations, and Management. Dental Clinics of North America. 2013;57(4):631–55. 66. Hahn BH. Systemic Lupus Erythematosus. In: Kasper D, Fauci A, Hauser S, Longo D, Jameson JL, Loscalzo J, editors. Harrison’s Principles of Internal Medicine, 19e. New York, NY: McGraw-Hill Education; 2015. 67. Anaya J-M, Leon KJ, Rojas M, Rodriguez Y, Pacheco Y, Acosta-Ampudia Y, et al. Progress towards precision medicine for lupus: the role of genetic biomarkers. Expert Review of Precision Medicine and Drug Development [Internet]. 2018 Mar 4;3(2):119–35. Available from: https://www.tandfonline.com/doi/full/10.1080/23808993.2018.1448266 68. James JA, Chen H, Young KA, Bemis EA, Seifert J, Bourn RL, et al. Latent autoimmunity across disease-specific boundaries in at-risk first-degree relatives of SLE and RA patients. EBioMedicine. 2019 Apr; In press. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30952617 69. Crow MK. Etiology and Pathogenesis of Systemic Lupus Erythematosus. In: KELLEY’S Textbook of Rheumatology. 9th ed. Philadelphia; 2013. p. 1269–82. 70. Inês L, Silva C, Galindo M, López-Longo FJ, Terroso G, Romão VC, et al. Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus Cohort. Arthritis care & research [Internet]. 2015 Aug;67(8):1180–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25581417 71. Karlson EW, Daltroy LH, Rivest C, Ramsey-Goldman R, Wright EA, Partridge AJ, et al. Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies. Lupus [Internet]. 2003;12(4):280–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12729051 72. Yu C, Gershwin ME, Chang C. Diagnostic criteria for systemic lupus erythematosus: A critical review. Journal of Autoimmunity [Internet]. 2014 Feb;48–49:10–3. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0896841114000067 73. McElhone K, Abbott J, Teh LS. A review of health related quality of life in systemic lupus erythematosus. Lupus [Internet]. 2006;15(10):633–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17120589 74. Schmeding A, Schneider M. Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus. Best practice & research Clinical rheumatology [Internet]. 2013 Jun;27(3):363–75. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24238693 75. Allanore Y, Simms R, Distler O, Trojanowska M, Pope J, Denton CP, et al. Systemic sclerosis. Nature reviews Disease primers [Internet]. 2015 Apr 23;1:15002. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27189141 76. Domsic RT, Rodriguez-Reyna T, Lucas M, Fertig N, Medsger TA. Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma. Annals of the rheumatic diseases [Internet]. 2011 Jan;70(1):104–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20679474 77. Barnes J, Mayes MD. Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers. Current opinion in rheumatology [Internet]. 2012 Mar;24(2):165–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22269658 78. Katsumoto TR, Whitfield ML, Connolly MK. The pathogenesis of systemic sclerosis. Annual review of pathology [Internet]. 2011;6:509–37. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21090968 79. Bhattacharyya S, Wei J, Varga J. Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities. Nature reviews Rheumatology [Internet]. 2011 Oct 25;8(1):42–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22025123 80. Shah AA, Wigley FM. My approach to the treatment of scleroderma. Mayo Clinic proceedings [Internet]. 2013 Apr;88(4):377–93. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23541012 81. van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis and rheumatism [Internet]. 2013 Nov;65(11):2737–47. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24122180 82. Man A, Correa JK, Ziemek J, Simms RW, Felson DT, Lafyatis R. Development and validation of a patient-reported outcome instrument for skin involvement in patients with systemic sclerosis. Annals of the rheumatic diseases [Internet]. 2017 Aug;76(8):1374–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28213563 83. Rojas M, Rodriguez Y, Pacheco Y, Zapata E, Monsalve DM, Mantilla RD, et al. Resilience in women with autoimmune rheumatic diseases. Joint, bone, spine [Internet]. 2018 Dec;85(6):715–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29289647 84. Kallenberg CG, Wouda AA, Hoet MH, van Venrooij WJ. Development of connective tissue disease in patients presenting with Raynaud’s phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Annals of the rheumatic diseases [Internet]. 1988 Aug;47(8):634–41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3261966 85. Weiner ES, Hildebrandt S, Senécal JL, Daniels L, Noell S, Joyal F, et al. Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud’s disease. A prospective study. Arthritis and rheumatism [Internet]. 1991 Jan;34(1):68–77. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1845841 86. Baubet T, Brunet M, Garcia De La Peña-Lefebvre P, Taïeb O, Moro M-R, Guillevin L, et al. [Psychiatric manifestations of systemic sclerosis]. Annales de medecine interne [Internet]. 2002 Jun;153(4):237–41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12218889 87. Mura G, Bhat KM, Pisano A, Licci G, Carta M. Psychiatric symptoms and quality of life in systemic sclerosis. Clinical practice and epidemiology in mental health : CP & EMH. 2012;8:30–5. 88. Nakayama A, Tunnicliffe DJ, Thakkar V, Singh-Grewal D, O’Neill S, Craig JC, et al. Patients’ perspectives and experiences living with systemic sclerosis: A systematic review and thematic synthesis of qualitative studies. Journal of Rheumatology. 2016;43(7):1363–75. 89. Nguyen C, Ranque B, Baubet T, Bérezné A, Mestre-Stanislas C, Rannou F, et al. Clinical, functional and health-related quality of life correlates of clinically significant symptoms of anxiety and depression in patients with systemic sclerosis: a cross-sectional survey. PloS one [Internet]. 2014;9(2):e90484. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24587375 91. Ostojic P, Zivojinovic S, Reza T, Damjanov N. Symptoms of depression and anxiety in Serbian patients with systemic sclerosis: impact of disease severity and socioeconomic factors. Modern rheumatology [Internet]. 2010 Aug;20(4):353–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20336476 92. Thombs BD, Jewett LR, Kwakkenbos L, Hudson M, Baron M, Canadian Scleroderma Research Group. Major depression diagnoses among patients with systemic sclerosis: baseline and one-month followup. Arthritis care & research [Internet]. 2015 Mar;67(3):411–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25156077 93. Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M, et al. Quality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditions. The Journal of rheumatology [Internet]. 2009 Apr;36(4):768–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19228662 94. Benrud-Larson LM, Haythornthwaite JA, Heinberg LJ, Boling C, Reed J, White B, et al. The impact of pain and symptoms of depression in scleroderma. Pain [Internet]. 2002 Feb;95(3):267–75. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11839426 95. Anaya J-M. ¿Qué es el síndrome de Sjögren y por qué es importante? In: Síndrome de Sjögren. 2nd ed. Bogotá; 2017. p. 3–10. 96. Moutsopoulos HM, Tzioufas AG. Sjögren Syndrome. In: Kasper D, Fauci A, Hauser S, Longo D, Jameson JL, Loscalzo J, editors. Harrison’s Principles of Internal Medicine, 19e. New York, NY: McGraw-Hill Education; 2015. 97. Castiblanco-Torres JL, Rojas-villarraga A. Anatomía y fisiología de las glándulas salivales. In: Síndrome de Sjögren. 2nd ed. Bogotá; 2017. p. 27–38. 98. Mavragani CP, Moutsopoulos NM, Moutsopoulos HM. The management of Sjögren’s syndrome. Nature clinical practice Rheumatology [Internet]. 2006 May;2(5):252–61. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16932698 99. Goules A V, Tzioufas AG, Moutsopoulos HM. Classification criteria of Sjögren’s syndrome. Journal of autoimmunity [Internet]. 2014;48–49(2014):42–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24456935 110. Ahern NR, Kiehl EM, Sole M Lou, Byers J. A review of instruments measuring resilience. Issues in comprehensive pediatric nursing [Internet]. 2006;29(2):103–25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16772239 111. Evers AWM, Zautra A, Thieme K. Stress and resilience in rheumatic diseases: A review and glimpse into the future. Nature Reviews Rheumatology. 2011;7(7):409–15. 112. Wohleb ES, Franklin T, Iwata M, Duman RS. Integrating neuroimmune systems in the neurobiology of depression. Nature reviews Neuroscience [Internet]. 2016;17(8):497–511. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27277867 113. Kavelaars A, Heijnen CJ. Stress, genetics, and immunity. Brain, Behavior, and Immunity [Internet]. 2006 Jul;20(4):313–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16495034 114. Ménard C, Pfau ML, Hodes GE, Russo SJ. Immune and Neuroendocrine Mechanisms of Stress Vulnerability and Resilience. Neuropsychopharmacology. 2017;42(1):62–80. 115. Carmichael O, Lockhart S. The role of diffusion tensor imaging in the study of cognitive aging. Current topics in behavioral neurosciences [Internet]. 2012;11(November 2011):289–320. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22081443 116. Irwin M. Psychoneuroimmunology of depression: Clinical implications. Brain, Behavior, and Immunity. 2002;16(1):1–16. 117. Elenkov IJ, Chrousos GP. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Annals of the New York Academy of Sciences [Internet]. 2002 Jun;966(1):290–303. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12114286 118. Silverman MN, Deuster PA. Biological mechanisms underlying the role of physical fitness in health and resilience. Interface focus [Internet]. 2014 Oct 6;4(5):20140040. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25285199 119. Childs E, de Wit H. Regular exercise is associated with emotional resilience to acute stress in healthy adults. Frontiers in physiology [Internet]. 2014;5(May):161. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24822048 120. Baratta M V, Rozeske RR, Maier SF. Understanding stress resilience. Frontiers in behavioral neuroscience [Internet]. 2013 Feb;7:158. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24265608 121. Bartone PT, Ursano RJ, Wright KM, Ingraham LH. The impact of a military air disaster on the health of assistance workers. A prospective study. The Journal of nervous and mental disease. 1989 Jun;177(6):317–28. 122. Wagnild GM, Young HM. Development and psychometric evaluation of the Resilience Scale. Journal of nursing measurement [Internet]. 1993;1(2):165–78. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7850498 123. Smith BW, Epstein EM, Ortiz JA, Christopher PJ, Tooley EM. The Foundations of Resilience: What Are the Critical Resources for Bouncing Back from Stress? In: Prince-Embury S, Saklofske DH, editors. Resilience in Children, Adolescents, and Adults: Translating Research into Practice. New York, NY: Springer New York; 2013. p. 167–87. 124. Rodríguez-Rey R, Alonso-Tapia J, Hernansaiz-Garrido H. Reliability and validity of the Brief Resilience Scale (BRS) Spanish Version. Psychological assessment [Internet]. 2016 May;28(5):e101–10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26502199 125. Bartley EJ, Hossain NI, Gravlee CC, Sibille KT, Terry EL, Vaughn IA, et al. Race/Ethnicity Moderates the Association Between Psychosocial Resilience and Movement-Evoked Pain in Knee Osteoarthritis. ACR Open Rheumatology. 2019;1(1):16–25. 126. Faria DAP, Revoredo LS, Vilar MJ, Eulália Maria Chaves M. Resilience and treatment adhesion in patients with systemic lupus erythematosus. The open rheumatology journal [Internet]. 2014;8(1):1–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24665352 127. Tan-Kristanto S, Kiropoulos LA. Resilience, self-efficacy, coping styles and depressive and anxiety symptoms in those newly diagnosed with multiple sclerosis. Psychology, health & medicine [Internet]. 2015 Oct;20(6):635–45. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25588098 128. Azizoddin DR, Zamora-Racaza G, Ormseth SR, Sumner LA, Cost C, Ayeroff JR, et al. Psychological Factors that Link Socioeconomic Status to Depression/Anxiety in Patients with Systemic Lupus Erythematosus. Journal of clinical psychology in medical settings [Internet]. 2017 Dec;24(3–4):302–15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28776205 129. Rosemberg M-AS, Li Y, Seng J. Allostatic load: a useful concept for advancing nursing research. Journal of clinical nursing [Internet]. 2017 Dec;26(23–24):5191–205. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28177541 130. Herrmann M, Scholmerich J, Straub RH. Stress and rheumatic diseases. Rheumatic Disease Clinics of North America. 2000;26(4):737–63. 131. Battalio SL, Silverman AM, Ehde DM, Amtmann D, Edwards KA, Jensen MP. Resilience and Function in Adults With Physical Disabilities: An Observational Study. Archives of physical medicine and rehabilitation [Internet]. 2017 Jun;98(6):1158–64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27993585 132. Nakazawa K, Noda T, Ichikura K, Okamoto T, Takahashi Y, Yamamura T, et al. Resilience and depression/anxiety symptoms in multiple sclerosis and neuromyelitis optica spectrum disorder. Multiple sclerosis and related disorders [Internet]. 2018 Oct;25:309–15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30176401 133. Silverman AM, Verrall AM, Alschuler KN, Smith AE, Ehde DM. Bouncing back again, and again: a qualitative study of resilience in people with multiple sclerosis. Disability and rehabilitation [Internet]. 2017 Feb;39(1):14–22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26878245 134. Strand EB, Zautra AJ, Thoresen M, Ødegård S, Uhlig T, Finset A. Positive affect as a factor of resilience in the pain-negative affect relationship in patients with rheumatoid arthritis. Journal of psychosomatic research [Internet]. 2006 May;60(5):477–84. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16650588 135. Réus GZ, Moura AB de, Silva RH, Quevedo WRR and J. Resilience dysregulation in major depressive disorder: focus on glutamatergic imbalance and microglial activation. Vol. 15, Current Neuropharmacology. 2017. p. 1. 136. Alschuler KN, Arewasikporn A, Nelson IK, Molton IR, Ehde DM. Promoting resilience in individuals aging with multiple sclerosis: Results from a pilot randomized controlled trial. Rehabilitation psychology. 2018 Aug;63(3):338–48 137. Quiceno JM, Vinaccia S, Remor E. Empowerment program of resilience for rheumatoid arthritis patients. Revista de Psicopatología y Psicología Clínica. 2014;16(1):27. 138. Green SB. How Many Subjects Does It Take To Do A Regression Analysis. Multivariate behavioral research. 1991 Jul;26(3):499–510. 139. Franco J-S, Amaya-Amaya J, Molano-González N, Caro-Moreno J, Rodríguez-Jiménez M, Acosta-Ampudia Y, et al. Autoimmune thyroid disease in Colombian patients with systemic lupus erythematosus. Clinical endocrinology [Internet]. 2015 Dec;83(6):943–50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25382266 140. Rojas M, Rodríguez Y, Monsalve DM, Pacheco Y, Acosta-Ampudia Y, Rodríguez-Jimenez M, et al. Cytokine imbalance in patients with systemic sclerosis and resilience: the key role of interleukin-6. Clinical and experimental rheumatology [Internet]. 2019 Jan 10; Available from: http://www.ncbi.nlm.nih.gov/pubmed/30652681 141. Rodriguez Y, Ramírez-Santana C, Molano-González N, Anaya J-M, Rojas M, Monsalve DM, et al. Autoimmune Thyroid Disease In Euthyroid Subjects. Universidad del Rosario; 2018. 142. Tunnicliffe DJ, Singh-Grewal D, Chaitow J, Mackie F, Manolios N, Lin M-W, et al. Lupus Means Sacrifices: Perspectives of Adolescents and Young Adults With Systemic Lupus Erythematosus. Arthritis care & research [Internet]. 2016 Jun;68(6):828–37. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26414860 143. Hargardóttir H, van Helvoort HAC, Vonk MC, van den Hoogen FHJ, Dekhuijzen PNR, Heijdra YF. Exercise in systemic sclerosis intensifies systemic inflammation and oxidative stress. Scandinavian journal of rheumatology [Internet]. 2010;39(1):63–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20132073 144. Azar M, Rice DB, Kwakkenbos L, Carrier M-E, Shrier I, Bartlett SJ, et al. Exercise habits and factors associated with exercise in systemic sclerosis: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study. Disability and rehabilitation [Internet]. 2018 May;40(17):1997–2003. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28478701 145. Rannou F, Boutron I, Mouthon L, Sanchez K, Tiffreau V, Hachulla E, et al. Personalized Physical Therapy Versus Usual Care for Patients With Systemic Sclerosis: A Randomized Controlled Trial. Arthritis care & research [Internet]. 2017 Jul;69(7):1050–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27696703 146. Hudson M, Rojas-Villarraga A, Coral-Alvarado P, López-Guzmán S, Mantilla RD, Chalem P, et al. Polyautoimmunity and familial autoimmunity in systemic sclerosis. Journal of Autoimmunity [Internet]. 2008 Sep;31(2):156–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18644698 147. Molano-González N, Rojas M, Monsalve DM, Pacheco Y, Acosta-Ampudia Y, Rodríguez Y, et al. Cluster analysis of autoimmune rheumatic diseases based on autoantibodies. New insights for polyautoimmunity. Journal of autoimmunity [Internet]. 2019 Mar;98:24–32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30459097 148. Moinzadeh P, Aberer E, Ahmadi-Simab K, Blank N, Distler JHW, Fierlbeck G, et al. Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis. Annals of the rheumatic diseases [Internet]. 2015 Apr;74(4):730–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24389298 149. Zhu M, Liang Z, Wang T, Chen R, Wang G, Ji Y. Th1/Th2/Th17 cells imbalance in patients with asthma with and without psychological symptoms. Allergy and asthma proceedings [Internet]. 2016;37(2):148–56. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26932172 150. Köhler CA, Freitas TH, Maes M, de Andrade NQ, Liu CS, Fernandes BS, et al. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta psychiatrica Scandinavica [Internet]. 2017 May;135(5):373–87. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28122130 151. Kurzinski K, Torok KS. Cytokine profiles in localized scleroderma and relationship to clinical features. Cytokine [Internet]. 2011 Aug;55(2):157–64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21536453 152. Elomaa A-P, Niskanen L, Herzig K-H, Viinamäki H, Hintikka J, Koivumaa-Honkanen H, et al. Elevated levels of serum IL-5 are associated with an increased likelihood of major depressive disorder. BMC psychiatry [Internet]. 2012 Jan 9;12:2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22230487 153. Valkanova V, Ebmeier KP, Allan CL. CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. Journal of affective disorders [Internet]. 2013 Sep 25;150(3):736–44. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23870425 154. Brydon L, Walker C, Wawrzyniak AJ, Chart H, Steptoe A. Dispositional optimism and stress-induced changes in immunity and negative mood. Brain, behavior, and immunity. 2009 Aug;23(6):810–6. 155. Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine [Internet]. 1997 Nov;9(11):853–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9367546 156. Su S, Miller AH, Snieder H, Bremner JD, Ritchie J, Maisano C, et al. Common Genetic Contributions to Depressive Symptoms and Inflammatory Markers in Middle-Aged Men: The Twins Heart Study. Psychosomatic Medicine [Internet]. 2009 Feb;71(2):152–8. Available from: https://insights.ovid.com/crossref?an=00006842-200902000-00003 157. Maes M, Anderson G, Kubera M, Berk M. Targeting classical IL-6 signalling or IL-6 trans-signalling in depression? Expert opinion on therapeutic targets [Internet]. 2014 May;18(5):495–512. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24548241 158. Frommberger UH, Bauer J, Haselbauer P, Fräulin A, Riemann D, Berger M. Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. European archives of psychiatry and clinical neuroscience [Internet]. 1997;247(4):228–33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9332905 159. Kubera M, Kenis G, Bosmans E, Kajta M, Basta-Kaim A, Scharpe S, et al. Stimulatory effect of antidepressants on the production of IL-6. International immunopharmacology [Internet]. 2004 Feb;4(2):185–92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14996410 160. Dürk T, Panther E, Müller T, Sorichter S, Ferrari D, Pizzirani C, et al. 5-Hydroxytryptamine modulates cytokine and chemokine production in LPS-primed human monocytes via stimulation of different 5-HTR subtypes. International immunology [Internet]. 2005 May;17(5):599–606. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15802305 161. Pinho de Oliveira Ribeiro N, Rafael de Mello Schier A, Ornelas AC, Pinho de Oliveira CM, Nardi AE, Silva AC. Anxiety, depression and suicidal ideation in patients with rheumatoid arthritis in use of methotrexate, hydroxychloroquine, leflunomide and biological drugs. Comprehensive psychiatry [Internet]. 2013 Nov;54(8):1185–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23829886 162. Abdel-Magied RA, Kamel SR, Said AF, Ali HM, Abdel Gawad EA, Moussa MM. Serum interleukin-6 in systemic sclerosis and its correlation with disease parameters and cardiopulmonary involvement. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG [Internet]. 2016 Dec 23;33(4):321–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28079844 163. Sato S, Hasegawa M, Takehara K. Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis. Journal of dermatological science [Internet]. 2001 Oct;27(2):140–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11532378 164. Matsushita T, Hasegawa M, Hamaguchi Y, Takehara K, Sato S. Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis. The Journal of rheumatology [Internet]. 2006 Feb;33(2):275–84. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16465658 165. Khanna D, Denton CP, Lin CJF, van Laar JM, Frech TM, Anderson ME, et al. Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate). Annals of the rheumatic diseases [Internet]. 2018 Feb;77(2):212–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29066464 166. Zou G, Li Y, Xu R, Li P. Resilience and positive affect contribute to lower cancer-related fatigue among Chinese patients with gastric cancer. Journal of clinical nursing [Internet]. 2018 Apr;27(7–8):e1412–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29266530 167. Bruunsgaard H, Galbo H, Halkjaer-Kristensen J, Johansen TL, MacLean DA, Pedersen BK. Exercise-induced increase in serum interleukin-6 in humans is related to muscle damage. The Journal of physiology. 1997 Mar;499:833–41. 168. Steensberg A, Fischer CP, Keller C, Møller K, Pedersen BK. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. American journal of physiology Endocrinology and metabolism [Internet]. 2003 Aug;285(2):E433-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12857678 169. Sharif K, Watad A, Bragazzi NL, Lichtbroun M, Amital H, Shoenfeld Y. Physical activity and autoimmune diseases: Get moving and manage the disease. Autoimmunity reviews [Internet]. 2018 Jan;17(1):53–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29108826 170. Resnick B, Klinedinst NJ, Yerges-Armstrong L, Choi EY, Dorsey SG. The Impact of Genetics on Physical Resilience and Successful Aging. Journal of aging and health [Internet]. 2015 Sep;27(6):1084–104. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25818147 171. Epel ES, Lin J, Wilhelm FH, Wolkowitz OM, Cawthon R, Adler NE, et al. Cell aging in relation to stress arousal and cardiovascular disease risk factors. Psychoneuroendocrinology [Internet]. 2006 Apr;31(3):277–87. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16298085 172. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis and rheumatism [Internet]. 2010 Sep;62(9):2569–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20872595 173. Turesson C, Matteson EL. Cardiovascular risk factors, fitness and physical activity in rheumatic diseases. Current opinion in rheumatology. 2007 Mar;19(2):190–6. 174. Holdsworth SR, Gan P-Y. Cytokines: Names and Numbers You Should Care About. Clinical journal of the American Society of Nephrology : CJASN [Internet]. 2015 Dec 7;10(12):2243–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25941193 175. Brüggemann M, Osborn MJ, Ma B, Hayre J, Avis S, Lundstrom B, et al. Human antibody production in transgenic animals. Archivum immunologiae et therapiae experimentalis [Internet]. 2015 Apr;63(2):101–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25467949 Repositorio EdocUR-U. Rosario Universidad del Rosario instacron:Universidad del Rosario